← 產業報告目錄
Personalized Medicine Biomarkers Market Size, Share & Trends Analysis Distribution by Type (Genetic Biomarkers, Protein Biomarkers, Metabolite Biomarkers), By Application (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others), By End User (Hospitals, Diagnostic Laboratories, Research Institutions) and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-27頁數 165報告編號 INSIGHTACE-6662be4e4e
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the Personalized Medicine Biomarkers Market worldwide was assessed at USD 22.9 Bn. Analysts project it will develop to USD 59.1 Bn by 2031, at a CAGR of 12.8% spanning 2024 to 2031.
Personalized Medicine Biomarkers covers The Personalized Medicine Biomarkers Market represents a continuously developing area of healthcare focused on using biomarkers, which are biological markers such as proteins or genetic mutations for individu. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Personalized Medicine Biomarkers Market Snapshot
Chapter 4. Global Personalized Medicine Biomarkers Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Personalized Medicine Biomarkers Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Personalized Medicine Biomarkers Industry Trends
Chapter 5. Personalized Medicine Biomarkers Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share by Type, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type:
5.2.1. Genetic Biomarkers
5.2.2. Protein Biomarkers
5.2.3. Metabolite Biomarkers
Chapter 6. Personalized Medicine Biomarkers Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Application:
6.2.1. Oncology
6.2.2. Neurology
6.2.3. Diabetes
6.2.4. Autoimmune Diseases
6.2.5. Cardiology
6.2.6. Others
Chapter 7. Personalized Medicine Biomarkers Market Segmentation 3: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End Users:
7.2.1. Hospitals
7.2.2. Diagnostic Laboratories
7.2.3. Research Institutions
Chapter 8. Personalized Medicine Biomarkers Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Personalized Medicine Biomarkers Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.2.3. North America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.2.4. North America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2019-2031
8.3. Europe
8.3.1. Europe Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.3.3. Europe Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.3.4. Europe Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2019-2031
8.4. Asia Pacific
8.4.1. Asia Pacific Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.4.3. Asia Pacific Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts By Application, 2019-2031
8.4.4. Asia Pacific Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2019-2031
8.5. Latin America
8.5.1. Latin America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.5.3. Latin America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.5.4. Latin America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2019-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.6.3. Middle East & Africa Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.6.4. Middle East & Africa Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Agilent Technologies, Inc.
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Bio-Rad Laboratories, Inc.
9.2.3. Foundation Medicine, Inc.
9.2.4. Genomic Health, Inc
9.2.5. Guardant Health, Inc.
9.2.6. Illumina, Inc.
9.2.7. Luminex Corporation
9.2.8. Merck KGaA
9.2.9. Myriad Genetics, Inc
9.2.10. QIAGEN N.V
9.2.11. Roche Diagnostics
9.2.12. Siemens Healthineers
9.2.13. Thermo Fisher Scientific Inc.
9.2.14. Coriell Life Sciences.
9.2.15. Laboratory Corporation of America Holding
9.2.16. NeoGenomics Laboratories
9.2.17. Quest Diagnostics Incorporated
9.2.18. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們